New capabilities strengthen U.S. production, completing Moderna’s domestic end-to-end mRNA manufacturing network More than $140 million investment will create hundreds of highly skilled ...

Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management, as it targets up to 10% revenue ...

The new line of credit could ease pressure on the money-losing vaccine maker as it tries to chart its post-pandemic future.

At an analyst day event, Moderna said it wants to invest revenue from a hopefully expanded seasonal vaccine franchise into ...

With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...

CAMBRIDGE, MA / ACCESS Newswire / November 20, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it has closed a five-year ...

With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a ...

Moderna is to expand its US manufacturing capabilities with the onshoring of drug product manufacture to its existing Moderna ...

Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 ...

Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.